Search

everythinglearnresearchcommunity

for

Search:↓

Immune checkpoint inhibitors used in cancer therapy can cause hair loss, and understanding this can help manage the side effect.

Alopecia areata is a reversible, autoimmune-related hair loss that can have significant emotional impact and uncertain treatment effectiveness.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

The document does not confirm if radical prostatectomy is the best treatment for locally advanced prostate cancer.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

EGFR is crucial for preventing hair follicle inflammation and hair loss.

DHL-HisZnNa may help reduce hair loss from chemotherapy, but more research is needed.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

The conclusion is that proper signaling is crucial for hair growth and development, and errors can lead to cancer or hair loss.

A cancer patient's hair became permanently curly after treatment with nivolumab.

Phospholipases help maintain and restore skin and hair health, potentially leading to new treatments for related conditions.

The treatment combination is effective and generally safe for lung cancer.

Boron neutron capture therapy for head and neck cancer can cause side effects like mouth sores and skin irritation, which vary depending on where the treatment is aimed.

Men with early hair loss may have a higher risk of enlarged prostate and possibly prostate cancer due to shared hormonal factors.

Targeting DNA methylation can help treat skin disorders and cancers.

Dutasteride effectively treats hair loss and prostate issues.

Early sunburn treatment with certain inhibitors may reduce skin cancer risk.

Cancer treatments can cause hair loss, but it is often reversible and can be managed with scalp cooling and support.

Understanding tissue self-organization can improve treatments for diseases and advance regenerative medicine.

The cat had liver cancer and a related hair loss condition, with a likely cause being bile duct cancer.

A new compound was made that might help treat diseases related to male hormones.

Finasteride reduces prostate cancer risk but may increase high-grade cancer cases.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.

Hormonal contraceptives and related compounds can increase health risks like thrombosis and affect sexual function.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

Ocoxin improves quality of life for advanced ovarian cancer patients on chemotherapy.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.